DJS Antibodies
Megan Ingham is a Senior Research Associate at DJS Antibodies, with experience in various roles including Junior Scientist and Research Assistant since September 2017. Prior to this, Megan completed a Summer Research Scholarship at Newcastle University in June 2015, focusing on specific-molecule inhibitors for treating t(8;21) positive acute myeloid leukaemia. In June 2014, participation in a competitive Working in Industry Workshop organized by AkzoNobel provided insight into the operations of science-based industries. Megan holds an MRes in Neuroscience and a BSc Honours in Pharmacology from Newcastle University, completed between 2013 and 2017, and attended Dereham Sixth Form College from 2011 to 2013.
This person is not in any offices
DJS Antibodies
1 followers
DJS Antibodies is developing novel therapeutics to treat chronic inflammatory diseases. DJS does this through the discovery and development of novel therapeutic monoclonal antibodies against GPCRs. The company's breakthrough technology enables its to produce first-in-class antibody therapeutics to previously intractable disease targets.